{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-045464","form_type":"8-K","ticker":"IRON","cik":"0001816736","company_name":"Disc Medicine, Inc.","filed_at":"2024-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.656425+00:00","generated_at":"2026-06-05T15:37:10.667814+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Disc Medicine appoints Pamela Stephenson as CCO; grants inducement equity award","bullets":["Pamela Stephenson, MPH, named Chief Commercial Officer effective Feb 26, 2024.","Stephenson has 25+ years biopharma experience, most recently CCO of Albireo (acquired by Ipsen).","Inducement award: option to purchase 55,000 shares and RSU for 36,666 shares under Nasdaq Rule 5635(c)(4).","Option vests 25% on first anniversary, then monthly; RSU vests in four equal annual installments.","Company is clinical-stage biopharma focused on serious hematologic diseases (NASDAQ:IRON)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-045464","json":"https://secwatch.observer/filing/0001193125-24-045464.json","markdown":"https://secwatch.observer/filing/0001193125-24-045464.md","text":"https://secwatch.observer/filing/0001193125-24-045464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816736/000119312524045464/0001193125-24-045464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816736/000119312524045464/d794509d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T15:37:10.667814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}